BackTalaris Therapeutics Overview

Talaris Therapeutics Total Assets

Talaris Therapeutics's total assets is $270M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$269.30M
21.90% YoYΔ $-75.50M vs prior year quarter

Peer average

Loading

Talaris Therapeutics Total Assets History

Loading

Talaris Therapeutics vs. peers: Total Assets Comparison

Loading

Talaris Therapeutics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Talaris Therapeutics (TALS) FAQ

As of the most recent data (June 2025), TALS shows a total assets of $270M. That compares with $340M in the prior-year period — down 21.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TALS's total assets is now $270M (was $340M) — a 21.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Talaris Therapeutics is outperforming or lagging.

Tracking TALS's total assets over time shows whether Talaris Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $270M That compares with $340M in the prior-year period — down 21.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Talaris Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $270M) with ownership activity and broader fundamentals.

Talaris Therapeutics's total assets is $270M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.